We expect Medtronic stock to trade sideways post-Q2 results announcement, with its revenues and earnings expected to miss the street estimates marginally.
There is more to the comparison, and in the sections below, we discuss why we believe ISRG stock will offer better returns than MDT stock in the next three years.